Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
95.40    -0.80 (-0.83%)
Bid:
96.00
Ask:
96.80
Spread: 0.80 (0.833%)
Market Cap: £580.22m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Syncona News

Syncona reports slight dip in net assets
10 Aug 2023

Syncona reports slight dip in net assets

(Sharecast News) - Healthcare investor Syncona reported a slight dip in net assets in its quarterly update on Thursday, to £1.24bn, down from ...

IN BRIEF: Syncona's portfolio Achilles Therapeutics net loss narrows
4 Aug 2023

IN BRIEF: Syncona's portfolio Achilles Therapeutics net loss narrows

Syncona Ltd - Healthcare company focused on developing its life science portfolio - Notes its portfolio company Archilles Therapeutics PLC's net loss ...

Syncona net asset value falls as cites economic uncertainty, inflation
15 Jun 2023

Syncona net asset value falls as cites economic uncertainty, inflation

(Alliance News) - Syncona Ltd on Thursday reported a lower net asset value per share at the end of March amid a "challenging" backdrop for the biotech...

LONDON BRIEFING: Stocks set lower after US Fed decision, ahead of ECB
15 Jun 2023

LONDON BRIEFING: Stocks set lower after US Fed decision, ahead of ECB

(Alliance News) - Stocks in London were set to open lower on Thursday, after the US Federal Reserve paused its interest rate hikes but indicated that ...

Syncona annual NAV falls in tough macro conditions
15 Jun 2023

Syncona annual NAV falls in tough macro conditions

(Sharecast News) - Health investor Syncona reported a fall in annual net asset value, driven by falls in its listed holdings and the partial write-dow...

Syncona launches new gene therapy company with GBP96 million funding
12 Jun 2023

Syncona launches new gene therapy company with GBP96 million funding

(Alliance News) - Syncona Ltd on Monday said it launched Beacon Therapeutics Holdings Ltd, a new ophthalmic therapy company, to treat patients with re...

Syncona launches retinal disease-focussed Beacon Therapeutics
12 Jun 2023

Syncona launches retinal disease-focussed Beacon Therapeutics

(Sharecast News) - Healthcare company developer and investor Syncona announced the launch of Beacon Therapeutics on Monday.